Patents by Inventor Hartmut Ney

Hartmut Ney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Patent number: 9468598
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: October 18, 2016
    Assignee: AstraZeneca AB
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
    Publication number: 20150290178
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: June 5, 2015
    Publication date: October 15, 2015
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
    Publication number: 20150290180
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 15, 2015
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
    Publication number: 20150290179
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 15, 2015
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Dosage form containing (S)-pantoprazole as active ingredient
    Patent number: 8758817
    Abstract: Dosage forms for oral administration of the magnesium salt of (S)-pantoprazole are described.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: June 24, 2014
    Assignee: Takeda GmbH
    Inventors: Rango Dietrich, Isabel Anstett-Klein, Marc Schiller, Hartmut Ney, Manfred Hartmann, Sabine Schäfer-Preuss
  • Dosage form containing pantoprazole as active ingredient
    Patent number: 8703192
    Abstract: Dosage forms for the oral administration of the magnesium salt of pantoprazole are described.
    Type: Grant
    Filed: April 3, 2009
    Date of Patent: April 22, 2014
    Assignee: Takeda GmbH
    Inventors: Isabel Anstett-Klein, Rango Dietrich, Hartmut Ney, Marc Schiller, Sabine Schaefer-Preuss, Manfred Hartmann
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20140031396
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP binder.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 30, 2014
    Applicant: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20140031397
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 30, 2014
    Applicant: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20130345265
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: April 30, 2013
    Publication date: December 26, 2013
    Applicant: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
    Patent number: 8465767
    Abstract: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
    Type: Grant
    Filed: May 21, 2008
    Date of Patent: June 18, 2013
    Assignee: Takeda GmbH
    Inventors: Rango Dietrich, Hartmut Ney
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20130131123
    Abstract: An immediate release solid dosage form in tablet or pellet form for oral administration of a PDE 4 inhibitor, comprising a PDE 4 inhibitor that is N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide (roflumilast) or a salt thereof, and one or more suitable pharmaceutical excipients; wherein said dosage form contains 500 ?g of the roflumilast or salt thereof.
    Type: Application
    Filed: January 11, 2013
    Publication date: May 23, 2013
    Applicant: Nycomed GmbH
    Inventors: Rango DIETRICH, Hartmut NEY, Klaus EISTETTER
  • Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
    Patent number: 8431154
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: April 30, 2013
    Assignee: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient
    Publication number: 20110251244
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: January 18, 2011
    Publication date: October 13, 2011
    Applicant: NYCOMED GMBH
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • DOSAGE FORM CONTAINING (S)-PANTOPRAZOLE AS ACTIVE INGREDIENT
    Publication number: 20110171303
    Abstract: Dosage forms for oral administration of the magnesium salt of (S)-pantoprazole are described.
    Type: Application
    Filed: March 23, 2011
    Publication date: July 14, 2011
    Applicant: NYCOMED GMBH
    Inventors: Rango DIETRICH, Isabel ANSTETT-KLEIN, Marc SCHILLER, Hartmut NEY, Manfred HARTMANN, Sabine SCHÄFER-PREUSS
  • Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Patent number: 7951397
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: May 31, 2011
    Assignee: Nycomed GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Pharmaceutical preparation comprising an active dispersed on a matrix
    Patent number: 7951398
    Abstract: The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation, an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohols, triglycerides, partial triglycerides and fatty acid esters.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: May 31, 2011
    Assignee: Nycomed GmbH
    Inventors: Rango Dietrich, Rudolf Linder, Hartmut Ney
  • Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Publication number: 20110060016
    Abstract: Disclosed is a method of treatment of COPD by oral administration of roflumilast.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: NYCOMED GMBH
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • Dosage form containing pantoprazole as active ingredient
    Publication number: 20090208571
    Abstract: Dosage forms for the oral administration of the magnesium salt of pantoprazole are described.
    Type: Application
    Filed: April 3, 2009
    Publication date: August 20, 2009
    Applicant: NYCOMED GmbH
    Inventors: Rango Dietrich, Isabel Anstett-Klein, Marc Schiller, Hartmut Ney, Manfred Hartmann, Sabine Schafer-Preuss
  • Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
    Publication number: 20080226712
    Abstract: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
    Type: Application
    Filed: May 21, 2008
    Publication date: September 18, 2008
    Applicant: NYCOMED GmbH
    Inventors: Rango Dietrich, Hartmut Ney
  • Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
    Patent number: 7402321
    Abstract: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: July 22, 2008
    Assignee: Nycomed GmbH
    Inventors: Rango Dietrich, Hartmut Ney